Literature DB >> 1424281

In vitro induction of IgG anti-DNA antibody from high density B cells of systemic lupus erythematosus patients by an HLA DR-restricted T cell clone.

M Murakami1, S Kumagai, M Sugita, K Iwai, H Imura.   

Abstract

An HLA-DR restricted T cell clone (26G11) which recognized a lymphoid cell-derived autoantigen associated with DR4 molecule was shown to induce not only autologous but also allogenic DR4+ B cells to produce large amounts of antibodies of the IgG and IgM classes. Using the helper activity of this clone, we investigated the mechanism of anti-DNA antibody production in DR-matched patients with systemic lupus erythematosus (SLE). When cultured with 26G11 cells, B cells from DR-matched normal control subjects produced large amounts of IgM anti-DNA antibody, but did not produce IgG anti-DNA antibody which is thought to have a pathological role in SLE. In contrast, B cells from DR-matched patients with active SLE spontaneously produced a fairly large amount of IgG anti-DNA antibody, and the production was augmented by the T cell clone. Little IgG anti-DNA antibody was produced by the B cells of patients with inactive SLE in either the presence or absence of T cell clone. We next fractionated B cells into low density B (LD-B) and high density B (HD-B) cells by centrifugation on discontinuous Percoll density gradients. IgG anti-DNA antibody was spontaneously produced by LD-B cells of active SLE patients but not by those either of inactive SLE patients or normal controls. On the other hand, although IgG anti-DNA antibody was not spontaneously produced by the HD-B cells of both active and inactive SLE patients, it could easily be induced by their culture with the T cell clone. Our results clearly show the existence of IgG anti-DNA antibody-producing B cells in the peripheral blood of SLE patients irrespective of their disease activity and suggest that autoreactive T cells may play a pathogenic role in SLE through the induction of autoantibody production.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1424281      PMCID: PMC1554619          DOI: 10.1111/j.1365-2249.1992.tb07936.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Demonstration of the requirement for self antigen in the activation of autoreactive T cells.

Authors:  M Sugita; S Kumagai; M Ota; H Inoko; K Tsuji; H Imura
Journal:  Int Immunol       Date:  1992-02       Impact factor: 4.823

Review 2.  Function of autoreactive T cells in immune responses.

Authors:  A Finnegan; B W Needleman; R J Hodes
Journal:  Immunol Rev       Date:  1990-08       Impact factor: 12.988

3.  Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus.

Authors:  A J Swaak; L A Aarden; L W Statius van Eps; T E Feltkamp
Journal:  Arthritis Rheum       Date:  1979-03

4.  Human B-lymphocyte subpopulations. I. Differentiation of density-separated B lymphocytes.

Authors:  M K Dagg; D Levitt
Journal:  Clin Immunol Immunopathol       Date:  1981-10

5.  Pathogenic anti-DNA autoantibody-inducing T helper cell lines from patients with active lupus nephritis: isolation of CD4-8- T helper cell lines that express the gamma delta T-cell antigen receptor.

Authors:  S Rajagopalan; T Zordan; G C Tsokos; S K Datta
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

6.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

7.  Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis.

Authors:  J B Winfield; I Faiferman; D Koffler
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

8.  Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function.

Authors:  J F Delfraissy; P Segond; P Galanaud; C Wallon; P Massias; J Dormont
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

9.  Immunoglobulin synthesis by peripheral blood cells in systemic lupus erythematosus.

Authors:  H E Jasin; M Ziff
Journal:  Arthritis Rheum       Date:  1975 May-Jun

10.  An improved ELISA for anti-native DNA by elimination of interference by anti-histone antibodies.

Authors:  R L Rubin; F G Joslin; E M Tan
Journal:  J Immunol Methods       Date:  1983-10-28       Impact factor: 2.303

View more
  5 in total

1.  Cationic and high affinity serum IgG anti-dsDNA antibodies in active lupus nephritis.

Authors:  R Suenaga; N I Abdou
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

2.  Functional activation of lymphocyte CD44 in peripheral blood is a marker of autoimmune disease activity.

Authors:  P Estess; H C DeGrendele; V Pascual; M H Siegelman
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

3.  B cell activation in clinically quiescent systemic lupus erythematosus (SLE) is related to immunoglobulin levels, but not to levels of anti-dsDNA, nor to concurrent T cell activation.

Authors:  P E Spronk; B T vd Gun; P C Limburg; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

4.  Restricted junctional diversity of T cell receptor delta gene rearrangements expressed in systemic lupus erythematosus (SLE) patients.

Authors:  C Olive; P A Gatenby; S W Serjeantson
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

5.  Association between vitamin D, oestradiol and interferon-gamma in female patients with inactive systemic lupus erythematosus: A cross-sectional study.

Authors:  Visnja Kokic; Dusanka Martinovic Kaliterna; Mislav Radic; Leida Tandara; Dijana Perkovic
Journal:  J Int Med Res       Date:  2017-12-13       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.